Article

Pharmacy Patient Satisfaction Highlights SPT Week in Review

Top articles of the week from Specialty Pharmacy Times.

5. Pharma Manufacturer Collaboration Seeks to Improve Drug Transparency

New medical information website provides pharmacists and other providers with both in-label and potential off-label medication information.

https://www.specialtypharmacytimes.com/news/pharma-manufacturer-collaboration-seeks-to-improve-drug-transparency

4. Meta-Analysis Finds Viagra Does Not Cause Melanoma

No evidence found that erectile dysfunction drugs cause melanoma.

https://www.specialtypharmacytimes.com/news/meta-analysis-finds-viagra-does-not-cause-melanoma

3. Pembrolizumab Approved for Any Solid Tumor Containing a Common Biomarker

Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.

https://www.specialtypharmacytimes.com/news/pembrolizumab-approved-for-any-solid-tumor-containing-a-common-biomarker

2. Sarilumab Receives FDA Approval for Rheumatoid Arthritis

Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.

https://www.specialtypharmacytimes.com/news/sarilumab-receives-fda-approval-for-rheumatoid-arthritis

1. Impact of Patient Satisfaction on Specialty Pharmacy

Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.

https://www.specialtypharmacytimes.com/news/impact-of-patient-satisfaction-on-specialty-pharmacy

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Lenacapavir | Image Credit: luchschenF | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com